Cleveland BioLabs gets funding for radiation treatment research

09/23/2009 | American City Business Journals

NIH's National Institute of Allergy and Infectious Diseases has given Cleveland BioLabs a $458,512 grant to continue research on Protectan CBLB502, an agent designed to protect against the damages caused by radiation exposure. Currently, no drug is approved for complications from radiation exposure.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Food & Drug Associate
Confidential
Washington, D.C., DC